Dew: My question is will the company inform shareholders as to either the specific or general nature of the questions?
Do you expect they will release something that will spell out even if they have to do a new clinical study or if these are questions about "non-clinical" data?
The last time, did anyone every find out what sort of questions they were asking?
Market Data 
Markets 
AI
